A study of 111,646 women found those taking Ozempic and similar GLP-1 drugs had 30% lower breast cancer rates. Here is what the data shows and does not show.
Services & Resources
© 2026 Thefirmo. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Service and Privacy Policy.
Legal & Compliance
Company
Editorial & Sections
Services & Resources
© 2026 Thefirmo. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Service and Privacy Policy.